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Formulation Development and Evaluation of Aspasomes
Containing Skin Whitening Agent
Mousumi Kar*, Md Saquib and Dinesh Kumar Jain
Email: mousumi.cop@gmail.com

Abstract
Skin darkening in elderly and middle age men and women has been a constant problem which is both aesthetic
as may also be pathological in nature. Demand for skin lightening cosmetics is immense, as many people wish
to modify, change, their skin colour, or for depigmenting skin in treatment of hyperpigmentation, freckles, or
lentigines. The major enzyme that is involved in the melanin synthesis is Tyrosinase and skin whitening may
occur in the event of the use of Tyrosine inhibitors which decrease or block the synthesis of melanin. For the
treatment of skin whitening, targeted biological vesicles may be used. In the present research, cholesterol and
negatively charged lipids were used along with Ascorbyl palmitate (ASP) and Quercetin (QZT) to formulate bilayer
vesicles. When the lipid formed the aspasomes, then Quercetin was encapsulated in the bilayer by sonication.
It was observed that when a combination of ascorbyl palmitate and Quercetin was used, a synergistic effect
was observed and could be used as a skin lightening cosmetic product. Quercetin inhibits tyrosinase formation
inhibiting melanin formation and ascorbyl palmitate has antioxidant and skin whitening property and is carrier.
The formulations were optimized for particle size and per cent drug entrapment at different temperature, volume
of hydration, and time of hydration. The content of Ascorbyl palmitate and cholesterol used had an effect on
the size and entrapment in the vesicles. Franz diffusion assembly was used to study the in-vitro transdermal
permeation of aspasomal QZT, aspasomal-QZT gel and QZT-solution across excised rat skin and it was found
that the results were best with the aspasomal QZT.
Key words: Ascorbyl palmitate, Skin whitening agent, Quercetin, vesicles, Transdermal penetration

Introduction
The demand for skin lightening cosmetics is
immense, as many people wish to modify, or
change, their skin colour, whilst others use it for
de-pigmenting the skin in the treatment of hyperpigmentation, freckles, or lentigines. Melanin
defenses the harmful effects of ultra violet light
of the sun and therefore skin lightening may be
achieved by blocking or somehow reducing the
effect of tyrosinase inhibitors. Tyrosinase is a
glycosylated, monooxygenase containing copper,
which is associated with many functions in our
body. It is widely available in nature. Primarily, this
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enzyme is associated with the initial two steps in
the melogenesis in mammals which is the process
of production of melanin (a dark macromolecule)
and is responsible to give a certain colour to hairs
and skin of mammals. Hyper-pigmentation occurs
upon the over-activity of this enzyme because of
the overproduction of melanin. When the enzyme
tyrosinase is inhibited, it leads to reduced melanin
production.
The amino acid L-tyrosine undergoes a two-step
hydroxylation to form L-3,4-dihydroxyphenylalanine,
L-DOPA, and then the oxidation of L-DOPA
occurs to form dopaquinone1. This quinone is a
highly reactive compound and can spontaneously
polymerize to form melanin. Therefore, the skin
whitening activity is usually studied through the
inhibition ability of dopachrome formation.
Ascorbic acid and various derivatives of it have
been used in the preparation of dermatological and
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cosmetic formulations. As it has the capability to
reduce skin pigmentation and melanin decomposition
and also improves skin elasticity by aiding collagen
formation hence finds its use in skin whitening
products. Ascorbic acid is less stable than Ascorbyl
palmitate. The synthetic lighteners may cause skin
sensitization and also show cytotoxic side effects.
Therefore, safer alternatives containing Quercetin,
and Vitamin C and its derivatives are useful and show
synergistic effects. Also, these do not have cytotoxic
effects to melanocytes. Quercetin is a potent inhibitor
of melanogenesis and is a flavonoid by nature. It also
decreases the intracellular tyrosinase activity. The
inhibition of melanogenesis by quercetin is found
to be due to both its tyrosinase inhibition activity
along with protein expression.
Quercetin is been found to be associated with either
inhibiting the biosynthesis of melanin biosynthesis
or cause for inhibition of free-radical formation. It
enhances collagen biosynthesis. But due to its low
chemical stability, the practical applications are
limited. When Ascorbyl palmitate is used along
with Quercetin, better skin absorption, especially
as a lipid based delivery system for topical delivery,
is observed. Aspasomes are lipophilic drug carrier
systems and can act as a local depot to improve drug
action for skin whitening and anti-ageing effects for
different classes of drugs.

Materials and Methods
Quercetin was obtained from Hi Media Laboratories,
Mumbai, India. Ascorbic acid-6-palmitate was
obtained from Sigma Chemicals, St Louis, M O,
USA; and Cholesterol from Loba Chemie Pvt Ltd.
Table 1: Formulation Codes of ASP Formulations
Ingredients
S No
(mol %)
1.
Ascorbyl palmitate
2.
Cholesterol
3.
Drug
4.
Chloroform and methanol (9:1)
5.
Phosphate buffer (pH 7.4)
For gel
1.
Carbopol-940
2.
Propylene glycol
3.
Methyl paraben
4.
Triethanolamine
5.
DM water
48
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Mumbai and Span 40 was obtained from SD fineChemicals Ltd, Mumbai. All other chemicals used
were of analytical grade.
Preparation of Aspasomes
Film hydration was used to prepare aspasomes
under nitrogen atmosphere, where the lipid mixture
(ascorbyl palmitate: cholesterol) in molar ratio
(Table 1) was mixed with Span 40. The drug was
added to a mixture of chloroform and methanol
and this system was kept under reduced pressure in
rotary evaporator at a temperature of 50 °C to form
a thin dry film on wall of round bottom flask. Then,
10 ml of phosphate buffered saline (PBS pH 7.4)
for hydration of the dried thin lipid film was added.
Ultrasonication was done for 2 minutes at 50% of
maximum output and then aspasomes were stored in
nitrogen-purged vials.
Preparation of Aspasomal-gel
Carbapol gel was added to the Aspasomes dispersion
in ratio of 1:1 (w/w) at 200 rpm/min for 5 minutes.
Various concentrations of Quercetin and carbapol
were prepared and parables along with 2–15% of
propylene glycol were added to the Aspasomal gels.
Characterization
Characterization of Aspasomes
Photomicrography
The
aspasomes
(unsonicated)
were
photomicrographed using a camera fitted over
microscope to confirm formation and pattern/nature
of vesicles.

Formulations
ASP1
ASP2
ASP3
ASP4
ASP5
ASP6
ASP7
50
55
45
40
60
75
25
50
45
55
60
40
25
75
20 mg
qs (As minimum quantity to dissolve Ascorbyl palmitate: cholesterol mixture).
qs (To make up volume up to 10 ml).
0.5-2.5 % w/w
15
0.2
To adjust pH
qs
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Size and size distribution
Aspasomal particle size and particle size distribution
was determined using a dynamic light scattering
system (Malvern 4700, Malvern, UK), where the
temperature was 90º and He-Ne laser system was
used.
Per cent entrapment
The Quercetin entrapment capacity was done by
centrifugation using a cooling micro centrifuge.
The specifications were 4 °C at 12,000 rpm for 15
minutes. The supernatant (free drug in PBS pH7.4)
and sediment (vesicle entrapping the Quercetin)
were collected separately. The supernatant and
sediment (lysis of vesicles by Triton X-100 0.5%
v/v or methanol) were removed and analyzed for
drug.
The entrapment efficiency was calculated using:
EE % = [(T-S)/ T] x 100
Where,
T is the total amount detected both in supernatant
and sediment.
S is the amount detected only in the supernatant.
Surface Morphology (SEM)
The SEM images were observed using Hitachi S-576
Scanning electron micrograph at a temperature of 25
± 2°C. For this, appropriate dilutions of aspasomal
dispersion were made and sonicated. A few drops of
formulation were placed on the grid and dried. After
drying, the photographs were taken.
Zeta potential
Malvern Zetasizer 2000 was used to measure zeta
potential of the formulations. The dispersion was
mixed with the PBS pH 7.4 and measurements were
taken in triplicate in multimodal mode. The charge
on vesicles and mean zeta potential values were
directly obtained.
Characterization of Aspasomal gel
Viscosity
Viscosity of gels was measured using Brookfield
digital viscometer. The TF S-96 spindle at 10 rpm
was used. Once gel settled at room temperature, the
measurements were taken.

Table 2: Formulation and physicochemical characterization of
quercetin aspasomes
Codes

Particle size
(nm)

Percent
Entrapment
Efficiency
(%)

Zeta
potential
(mv)

ASP 1

384.2±5.48

52.41±0.60

-48.2±2.4

ASP 2

414.8±6.42

46.72±0.86

-45.3±2.8

ASP 3

438.6±7.36

33.82±1.46

-42.4±5.4

ASP 4

498.8±7.64

27.42±1.20

-39.8±4.4

ASP 5

680.2±6.10

30.80±1.68

-36.2±3.3

ASP 6

632.7±5.84

25.56±2.80

-31.3±4.2

ASP 7

768.3±10.4

17.42±2.48

-27.6±3.8

Of Gel
Spreadability
(g.cm/s)

pH
value

Drug
content

APG 1

32.42

33480±2.54

7.1

91.4

APG 2

24.28

37520±3.20

6.8

89.5

APG 3

16.38

43780±1.82

6.7

87.3

APG 4

9.44

50220±3.48

6.4

88.3

APG 5

5.62

54220±2.20

6.3

82.2

Spreadability
A wooden block and glass was used to determine
spreadabilty. A wooden block was fixed with a pulley
and glass slide and a pan was attached. Measured
amount of the gel was placed on fixed glass slide so
that the gel was exactly between the two slides for a
duration of 5 minutes. The total time taken for the
slides to separate was noted. The experiment was
done in triplicate and the results noted.
Spreadability was determined using formula:
S=M.L/T
Where,
S is spreadabilty in gm-cm/sec,
M is mass in grams,
L is glass length and
T is time in seconds.
Extrudability
Extrudability was determined by finding out
the amount of gel extruded from the lacquered
aluminium collapsible tube containing the gel.
Upon removal of the cap, the gel extruded out until
pressure dissipated. The weight of 0.5 cm ribbon
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of the extruded aspasomal-gel in 10 seconds was
determined using the formula”
E = (We /Wt) X 100
Where,
E = % Extrudability
We = Amount of gel extruded in g
Wt = Total amount of gel in the tube in g
Measurement of pH
Digital pH meter at a constant temperature was
used to measure pH of the gel.
Drug content
One gram of Aspasomal gel was diluted with 10 ml
of distilled water containing Triton X-100 (0.5%
v/v) to cause lysis of vesicles. It was mixed to get
a slightly opaque dispersion and the centrifuged
at 3,000 rpm for 30 minutes. The supernatant was
filtered through the polycarbonate membrane filter
(0.20 µm) and diluted with 10 ml of distilled water
and analyzed for drug. The Quercetin concentration
was determined by measuring absorbance at 369 nm
using UV-spectrophotometer.
Comparative evaluation of Developed system and
Aspasomal gel
In vitro release study
Release studies were carried out after removing
un-entrapped Quercetin by dialyzing the original
preparation. A dialysis membrane (Hi-Media,
Mumbai) weight cut off between 12,000 and 14,000
daltons was used. Pre-soaked membrane (phosphate
buffer pH 7.4 for 12 hours) was used and 5 ml of
dialyzed preparation was added and release studies
carried out taking 100 ml of PBS 7.4 in receptor
cell. Aliquots (5 ml) were withdrawn at regular
intervals and refreshed with fresh buffer. The

study was carried out for 18 hours. Samples were
analyzed for Quercetin using Ultraviolet (UV)
spectrophotometer. The same was repeated with
aqueous Quercetin solution and aspasomal-gel.
All experiments were performed in triplicate and
reported as mean ± standard deviation.
In vitro Transdermal permeation
The in-vitro permeation of the formulations
was studied using Franz diffusion assembly at a
temperature of 32 ± 1°C. Phosphate buffer saline pH
6.4 (16 ml) was placed in the receptor compartment
and stirred at 100 rpm using a magnetic stirrer. The
dorsal skin was excised of the sacrificed rat and kept
in distilled water initially, then placed on aluminium
foil and the adhering fat and/or subcutaneous
tissue from the dermal side of skin were gently
removed. This skin was mounted onto the receptor
compartment with the stratum corneum side
facing upward into the donor compartment and the
aspasomal formulation (200 µl) was applied.
One ml of aliquots were withdrawn through the
sampling port at predetermined time intervals
over 24 hours, replenished with equal volume of
fresh buffer and analyzed for drug content. The
experiments were performed in triplicates. Same
were performed with aqueous Quercetin solution,
and aspasomal-gel and the cumulative amount of
drug permeated determined.
In vivo study
Depigmenting Activity
Depigmenting activity was evaluated in mice. Five
week old mice were selected with weights ranging
from 20 gms-25 gms and housed in stainless steel
cages (temperature 25-28°C ) and with alternating
day and night cycles of 12 hours. The animals were
allowed to adjust for 7 days prior to the experiment.
The hairs were shaven and then the animals were

Table 3: Stability studies of ASP-QZT dispersion and ASP-QZT gel
ASP-quercetin dispersion
Number of
days

Entrapment efficiency
(%)
4-80C

ASP-quercetin gel

Vesicle size (nm)

RT

4-80C

RT

Viscosity

Drug content

4-80C

RT

4-80C

RT

0

52.43

52.26

348.6

348.6

34360 ±2.54

34360 ±2.54

91.4

91.3

15

51.24

49.45

350.8

352.4

38640 ±1.92

39530 ±1.92

90.8

90.6

30

49.18

46.68

352.5

360.9

87.7

88.5
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allowed a day rest. Then, UV irradiations were
directed daily for 30 seconds using eight Philips
TL12/20 W fluorescent sunlamp tubes which were
positioned at 35 cm. The lamp emitted radiations
between 210 nm-300 nm. The daily dose was kept at
99 mJ⁄cm2. Mice were kept unrestrained during the
procedure. After the pigmentation was developed,
the standard sample was applied. Four groups of
three mice, and each were smeared twice daily with
hydrogel (control), 2% Quercetin cream (standard),
2% ASP Quercetin gel. The applications continued
for four weeks and the skin-whitening effect was
measured on the skin every day and photographic
images were taken.
Skin irritation studies
The albino rats of either sex weighing 20‐22
g were used. Intact skin after hair removal before
three days of experiments was taken for the
study. Four groups of animals were taken and
aspasomal gel was applied on test animal. A
piece of cotton wool, soaked in saturated drug
solution was placed on the back of mice taken
as control. The animals were treated daily for
seven days and the treated skin was visually
examined for erythema and edema.

Stability studies
The optimized ASP dispersion batch ASP1 and
its optimized batch of Aspasomal gel APG1 were
kept in sealed vials (30 ml capacity) and stored at
2o-8oC (refrigerated temperature), 25 ± 2oC (room
temperature, RT) for three months. Samples at each
temperature conditions were taken at different time
intervals and then observed under microscope for
change in consistency (crystal formation) and drug
retention. The drug retention was determined
by centrifuging the sample at 12,000 rpm for 30
minutes and the supernatant analyzed for free drug.
The experiments were performed in triplicate (n=3).

Results and Discussions
Photomicrography of aspasomes was done and it was
found that multilaminar vesicles (Fig 1) are formed.
The mean diameter of the aspasomal dispersions
was 520 nm with a size distribution of 350 nm to
800 nm before the process of lyophylization. The
entrapment efficiency of quercetin aspasomes was
found to be maximum in (52.41%) in which the
concentration of ascorbyl palmitate and cholesterol
are equal. The Scanning Electron Microscopy
analysis (SEM) of quercetin aspasomes is shown
in Figure 1. It indicates that the aspasomes are bilayered with almost spherical shape and uniform
size. Zeta potential was determined and found to be
between -27.6±3.8 to -48.2±2.4 and 0.433 to 0.970
respectively.

Figure 1: SEM image of optimized formulations
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Published by Impressions@MAHE, 2022

51

5

Manipal Journal of Pharmaceutical Sciences, Vol. 6 [2022], Iss. 1, Art. 8
Kar M et al: Formulation Development and Evaluation of Aspasomes Containing Skin Whitening Agent

formulation was better than other formulation
therefore it was taken for further study.
In vitro studies of developed system and aspasome
gel was performed and in the study up to 78% of
drug released rapidly and then the release was
linear, after which the drug release rate decreased.
In comparative percentage in-vitro drug release of
Plain QZT, Aspasomal QZT, and Aspasomal QZT
gel, it was found that the Aspasomal QZT-gel
showed much slower release rate than Aspasomal
QZT and plain QZT. In the drug permeation
study, quercetin aspasomes permeation on topical
application was better than the plain quercetin and
aspasomal quercetin gel.

(C) AFTER ONE MONTH OF TREATMENT
Figure 2: Depigmentation Activity of formulations

Aspasomal Gel Formulation
Psychorheological characteristic of Aspasomal
Gel was found that all the formulations were
smooth, clear, transparent and shows no clogging
which indicates the good texture of formulation
and excellent homogeneity. In APG1, formulation
concentration of carbopol 940 was 0.5 % so the
viscosity of this formulation was found to be
34,360 ± 2.54 cps which was gradually increased
due to increase concentration of carbopol 940. The
spreadability values are shown in range of 6.67
- 30.34 g.cm/s. However the spreadability values
decreased with the concentration of carbopol in
gel. The decrease in spreadability was due to the
increase in the viscosity of gel. Extrudability of all
gel formulation was excellent, the gel containing 0.5
carbopol extrudes easily and the value decreases with
the concentration of carbopol 940 but all formulation
shows very good to excellent extrudability. The pH
of all formulations were in the range of 6-7 that
suited the skin indicating the skin compatibility and
it is primary requirement. There was no significant
difference observed in the percentage of drug at
various locations, indicating that the method used to
disperse the aspasomal dispersion in the gel base is
satisfactory. It was clear from the results that APG1
52
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In-vivo skin irritation which was a visual examination
for erythema and edema showed no evidence on test
subjects during the two week treatment period. In
the depigmentation studies, topical application
of quercetin to hairless mice skin showed time
related depigmentation of treated sites during
the 30 day treatment (Fig 2). Topical application
of the aspasomal gel did not cause any visible
pigmentary change or local irritation. Definite
visual depigmentation was noted after 15, 20, and 25
days, respectively. The visual depigmentation with
marketed preparation (standard) and aspasomal
QZT gel was observed.
Stability studies of ASP-QZT dispersion, ASPQZT lyophilized and ASP-QZT gel was performed
and after three months of storage at 40C and RT,
no significant changes in the size of all formulations
were found. Though, the entrapment of the
ASP formulations fell by about 5% in ASP-QZT
dispersion. This result may be due to the crystal
transition of cholesterol caused by temperature and
storing. ASP-QZT lyophilized and ASP-QZT gel
exhibited a good stability. No obvious changes in
clarity of preparation were found.
Ascorbyl palmitate forms vesicles (Aspasomes) in
presence of cholesterol, encapsulating Quercetin
solution. The antioxidant potency and its capability
to suppress pigmentation of the skin can be used
for skin whitening and may find applications as
drug delivery system for whitening or brightening
the pigmented skin. Aspasomes also significantly
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enhanced the transdermal permeation of Quercetin
compound. The antioxidant property and lipophilic
character suggest its use for transdermal drug
delivery system.
Conclusions
Ascorbyl palmitate is widely used in cosmetic and
drug industry as an antioxidant. But the major
problem that is associated with the chemical is its
poor solubility and oxidative instability which is
mostly seen in colloidal systems. When formulated
as aspasomes it was found that the stability and
penetration was better and this lead to enhanced
bioavailability of the drug. The results indicate that
aspasomal formulations are efficient in treatment
of skin pigmentation disorders and produce
whitening effect on skin. Thus, these can be used
for antioxidant and skin whitening effects. Further
studies are needed to follow the long term effects of
the formulation.
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